Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
J Antimicrob Chemother ; 78(10): 2462-2470, 2023 10 03.
Artigo em Inglês | MEDLINE | ID: mdl-37583091

RESUMO

BACKGROUND: Risk factors for carbapenem resistance in Enterobacterales bloodstream infections among children with cancer or post-HSCT have not been thoroughly explored. METHODS: All children with cancer or post-HSCT who developed Enterobacterales bloodstream infections in two cancer referral centres in major Colombian cities between 2012 and 2021 were retrospectively examined. When the infection episode occurred, carbapenem resistance mechanisms were evaluated according to the available methods. Data were divided in a training set (80%) and a test set (20%). Three internally validated carbapenem-resistant Enterobacterales (CRE) prediction models were created: a multivariate logistic regression model, and two data mining techniques. Model performances were evaluated by calculating the average of the AUC, sensitivity, specificity and predictive values. RESULTS: A total of 285 Enterobacterales bloodstream infection episodes (229 carbapenem susceptible and 56 carbapenem resistant) occurred [median (IQR) age, 9 (3.5-14) years; 57% male]. The risk of CRE was 2.1 times higher when the infection was caused by Klebsiella spp. and 5.8 times higher when a carbapenem had been used for ≥3 days in the previous month. A model including these two predictive variables had a discriminatory performance of 77% in predicting carbapenem resistance. The model had a specificity of 97% and a negative predictive value of 81%, with low sensitivity and positive predictive value. CONCLUSIONS: Even in settings with high CRE prevalence, these two variables can help early identification of patients in whom CRE-active agents are unnecessary and highlight the importance of strengthening antibiotic stewardship strategies directed at preventing carbapenem overuse.


Assuntos
Gammaproteobacteria , Transplante de Células-Tronco Hematopoéticas , Neoplasias , Sepse , Humanos , Criança , Masculino , Adolescente , Feminino , Estudos Retrospectivos , Carbapenêmicos/farmacologia , Carbapenêmicos/uso terapêutico , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico
2.
R Soc Open Sci ; 3(7): 160231, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-27493778

RESUMO

Birds in cities start singing earlier in the morning than in rural areas; commonly this shift is attributed to light pollution. Some studies have suggested that traffic noise has a stronger influence on singing activity than artificial light does. Changes in the timing of singing behaviour in relation to noise and light pollution have only been investigated in the temperate zones. Tropical birds, however, experience little seasonal variation in day length and may be less dependent on light intensity as a modifier for reproductive behaviours such as song. To test whether noise or light pollution has a stronger impact on the dawn chorus of a tropical bird, we investigated the singing behaviour of rufous-collared sparrows (Zonotrichia capensis) in Bogota, Colombia at two times during the year. We found that birds in places with high noise levels started to sing earlier. Light pollution did not have a significant effect. Birds may begin to sing earlier in noisy areas to avoid acoustic masking by traffic later in the morning. Our results also suggest that some tropical birds may be less sensitive to variations in day length and thus less sensitive to light pollution.

3.
Biomedica ; 34 Suppl 1: 81-90, 2014 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-24968039

RESUMO

INTRODUCTION: KPC enzymes are carbapenemases with a great capability to disseminate and to cause epidemics. They are frequently associated with higher mortality rates and prolonged hospital stay. In Colombia, they have been progressively reported since 2007; however, its prevalence in hospitals is not known. OBJECTIVE: To estimate the prevalence of bla KPC gene in hospitals. METHODS AND MATERIALS: The presence of bla KPC gene and its clonality were evaluated in clinical isolates of Enterobacteriacea and Pseudomonas aeruginosa in hospitalized patients. RESULTS: Of the 424 isolates tested during the study period, 273 met eligibility criteria, and 31.1% were positive for bla KPC gene; after clonality adjustment, positivity was 12.8%. The bla KPC gene was more frequent in Klebsiella pneumonia, followed by P. aeruginosa and other Enterobacteriacea . Although intensive care units (ICU) provided the majority of the isolates, the bla KPC pattern was not more prevalent in ICUs than in other wards. The respiratory tract was the anatomic source with the highest prevalence. No seasonality was observed associated with the frequency of isolation of microorganisms carrying bla KPC gene. CONCLUSION: This study revealed a high prevalence of bla KPC gene in microorganisms isolated from different hospitals in Colombia. The extraordinary ability of bla KPC gene to spread, the difficulties for its diagnosis and the limited antibiotics available for its treatment pose the urgent need to strengthen epidemiological surveillance systems, and to timely adjust institutional policies for rational use of antibiotics in order to limit its dissemination to other institutions in the country.


Assuntos
Proteínas de Bactérias/genética , Farmacorresistência Bacteriana Múltipla/genética , Bactérias Gram-Negativas/genética , Infecções por Bactérias Gram-Negativas/microbiologia , Resistência beta-Lactâmica/genética , beta-Lactamases/genética , Adolescente , Adulto , Idoso , Criança , Colômbia , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/microbiologia , Estudos Transversais , Genes Bacterianos , Bactérias Gram-Negativas/enzimologia , Bactérias Gram-Negativas/isolamento & purificação , Infecções por Bactérias Gram-Negativas/epidemiologia , Hospitais Urbanos , Humanos , Lactente , Unidades de Terapia Intensiva , Masculino , Pessoa de Meia-Idade , Fenótipo , Prevalência
4.
Biomédica (Bogotá) ; Biomédica (Bogotá);29(2): 270-281, jun. 2009. tab, graf
Artigo em Espanhol | LILACS | ID: lil-544516

RESUMO

Introducción. La malaria, la anemia y las parasitosis coexisten en niños colombianos. Se desconoce el efecto del suplemento de retinol y de los antiparasitarios sobre estos problemas de salud y la evolución de la hemoglobina, el retinol, la ferritina y la proteína C reactiva, en niños palúdicos. Objetivo. Comparar el efecto de la intervención simultánea con antipalúdicos, antiparasitarios y un suplemento de retinol sobre la evolución de la hemoglobina, la ferritina, el retinol y la proteína C reactiva, en niños palúdicos. Materiales y métodos. Estudio experimental no ciego de 93 niños palúdicos de 4 a 10 años, con asignación aleatoria a uno de los siguientes grupos: uno recibió antipalúdico y suplemento de retinol (grupo MA); otro, antipalúdico, suplemento de retinol y antiparasitarios (grupo MAP); otro, antipalúdico y antiparasitarios (grupo MP) y otro, sólo antipalúdico (grupo M); se siguieron 30 días, se evaluaron los cambios de hemoglobina, ferritina, retinol y proteína C reactiva, 8 y 30 días después. Resultados. En el total de los niños, el día del ingreso los promedios de las determinaciones fueron: hemoglobina, 10,3±1,6 g/dl; retinol, 19,1±6,0 μg/dl; proteína C reactiva, 75±63 mg/L, y ferritina, 213±203 μg/L. Al día 30, las concentraciones de hemoglobina y retinol aumentaron en 1,4±1,4g/dl y 11,5±8,1 μg/dl, respectivamente, mientras que las concentraciones de proteína C reactiva y ferritina disminuyeron en 66±60 mg/L y 184±203 μg/L, respectivamente, sin diferencias estadísticamente significativas entre los grupos de tratamiento. Los cambios el día 8 sólo fueron diferentes por grupo para la hemoglobina, que incrementó en el grupo MAP, diferente a los otros grupos. Conclusión. El día 30, la hemoglobina y el retinol aumentaron, y la proteína C reactiva y la ferritina disminuyeron. El suplemento de retinol y antiparasitarios simultáneos previno la reducción de hemoglobina al día 8, sin afectar los cambios en otras variables.


Introduction. Malaria, anemia and intestinal parasitism can co-exist in certain populations of Colombian children. The effects of retinol supplementation and anti-intestinal parasite treatment in children with malaria is unknown. Changes after this treatment of with respect to hemoglobin, retinol, ferritin and C reactive protein levels have not been previously monitored. Objective. The effect of simultaneous intervention with antimalarial, retinol supplementation and anti-intestinal parasites treatment will be monitored by examining levels of hemoglobin, ferritin, retinol and C reactive protein in children with malaria. Materials and methods. A non-blind experimental study was conducted in 93 children with malaria, aged 4-10 years. Each was randomly allocated to one of the following groups: (1) treatment with antimalarial and retinol supplement (Group MA); (2) treatment with antimalarial-retinol supplement and anti-parasitic drug (Group MAP); (3) treatment with antimalarial and anti-parasitic drug (Group MP), and (4) treatment only with antimalarials (Group M). The groups were observed for 30 days, with haemoglobin, ferritin, retinol and C reactive protein evaluated on days 0, 8 and 30 after treatment. Results. Mean values for the children at day 0 were as follows: hemoglobin 10.3±1.6 g/dL, retinol 19.1±6.0 μg/dL, C reactive protein 75±63 mg/L and ferritin 213±203 μg/L. On day 30 after treatment, hemoglobin and plasma retinol concentrations increased in 1.4±1.4 g/dL and 11.5±8.1 μg/dL, whereas the C reactive protein and ferritin concentrations decreased to 66±60 mg/L, and 184±203 μg/L, respectively. No statistically significant differences appeared among the groups. On day 8, significant differences between the groups were observed in hemoglobin concentrations Group MAP was higher when compared to other groups. Conclusion. On day 30, hemoglobin and retinol were high, whereas C reactive protein was low...


Assuntos
Criança , Anemia , Malária , Vitamina A , Colômbia
5.
Iatreia ; Iatreia;22(1): 27-46, mar. 2009. tab
Artigo em Espanhol | LILACS | ID: lil-554024

RESUMO

Introducción: malaria, parasitosis intestinales y desnutrición coexisten e interactúan en los habitantes de las zonas palúdicas; se requiere conocer la magnitud de cada una de esas enfermedades. Objetivo: identificar la prevalencia de parásitos intestinales en niños (4-10 años) de Urabá y Bajo Cauca (Antioquia, Colombia) y conocer el cambio postratamiento antiparasitario intestinal específico. Metodología: en niños con paludismo, se hicieron encuestas parasitarias intestinales antes y 8 y 30 días postratamiento (albendazol + secnidazol). Se usaron coprológicos directo y por concentración, en muestra única. Resultados: el día-1, 80% mostraron algún helminto patógeno y 39%, algún protozoo patógeno; hubo helmintos y protozoos patógenos en 35%. Las prevalencias específicas el día 1 fueron: Ascaris lumbricoides 43,5%, Trichuris trichiura 68,2%, Necator americanus 37,6%, Entamoeba histolytica 15,3%, Giardia lamblia 21,2%. La intensidad parasitaria protozoaria fue siempre baja (1-2 cruces) y por helmintos fue moderada-intensa en 84% para A. lumbricoides, 83% para T. trichiura y 50% para N. americanus. Medida el día 8, la “reducción neta de la prevalencia protozoaria”, atribuible al tratamiento, fue: E. histolytica 50%, G. lamblia 71% (p < 0,05). Medida el día 8, la “reducción neta de la intensidad de helmintos”, atribuible al tratamiento, fue significativa para A. limbricoides y N. americanus. La reducción neta por el albendazol medida al día 8 fue: A. lumbricoides 91%, N. americanus 87%, T. trichiura 27%; siempre fue significativa la reducción de la cantidad de huevos (p < 0,05). Conclusión: las parasitosis intestinales en Turbo y El Bagre, en niños maláricos de 4-10 años, tienen muy alta prevalencia y constituyen un grave problema de salud pública.


Introduction: Malaria, intestinal parasitoses and malnutrition coexist and interact in people of malarious areas; it is required to know the magnitude of these diseases. Objective: to identify the prevalence of intestinal parasites in children (aged 4-10 years) of malarious areas of Antioquia (northwestern Colombia), and to know the changes of parasites at days 8 and 30 after specific treatment. Methodology: intestinal parasites surveys were applied before treatment (albendazole + secnidazole) and at days 8 and 30 after treatment. Examination of stools (direct and concentration) were used in single samples. Results: at day 1, 80% of the children showed some pathogenic helminth, 39% had some pathogenic protozoan, and 35% had both helminths and protozoa. Specific prevalences at day 1 were as follows: Ascaris lumbricoides 43.5%, Trichuris trichiura 68.2%, Necator americanus 37.6%, Entamoeba histolytica, 15.3%, Giardia lamblia 21.2%. The intensity of infection was slight (1-2 crosses) for protozoan parasites and it was moderateintense for helminth parasites, namely: 84% for A. lumbricoides, 83% for T. trichiura and 50% for N. americanus. The “net effect on protozoan prevalence” attributable to treatment, measured at day 8, was E. histolytica 50% and G. lamblia 71% (p < 0.05). The “net effect on helminth burden” (NEHB) attributable to treatment (between days 1 and 8) was significant for A. lumbricoides and N. americanus. The NEHB of albendazole, measured at day 8, was 91% for A. lumbricoides, 27% for T. trichiura and 87% for N. americanus. Egg reduction was always significant (p < 0.05). Conclusion: Prevalence rates of intestinal parasites in Turbo and El Bagre, in children with malaria, aged 4-10 years, are still high and constitute a severe public health problem.


Assuntos
Ascaris , Entamoeba , Giardia , Malária , Necator , Criança , Strongyloides , Trichuris
6.
Biomedica ; 29(2): 270-81, 2009 Jun.
Artigo em Espanhol | MEDLINE | ID: mdl-20128352

RESUMO

INTRODUCTION: Malaria, anemia and intestinal parasitism can co-exist in certain populations of Colombian children. The effects of retinol supplementation and anti-intestinal parasite treatment in children with malaria is unknown. Changes after this treatment of with respect to hemoglobin, retinol, ferritin and C reactive protein levels have not been previously monitored. OBJECTIVE: The effect of simultaneous intervention with antimalarial, retinol supplementation and anti-intestinal parasites treatment will be monitored by examining levels of hemoglobin, ferritin, retinol and C reactive protein in children with malaria. MATERIALS AND METHODS: A non-blind experimental study was conducted in 93 children with malaria, aged 4-10 years. Each was randomly allocated to one of the following groups: (1) treatment with antimalarial and retinol supplement (Group MA); (2) treatment with antimalarialretinol supplement and anti-parasitic drug (Group MAP); (3) treatment with antimalarial and antiparasitic drug (Group MP), and (4) treatment only with antimalarials (Group M). The groups were observed for 30 days, with haemoglobin, ferritin, retinol and C reactive protein evaluated on days 0, 8 and 30 after treatment. RESULTS: Mean values for the children at day 0 were as follows: hemoglobin 10.3 +/- 1.6 g/dL, retinol 19.1 +/- 6.0 microg/dL, C reactive protein 75 +/- 63 mg/L and ferritin 213 +/- 203 microg/L. On day 30 after treatment, hemoglobin and plasma retinol concentrations increased in 1.4 +/- 1.4 g/dL and 11.5 +/- 8.1 microg/dL, whereas the C reactive protein and ferritin concentrations decreased to 66 +/- 60 mg/L, and 184 +/- 203 microg/L, respectively. No statistically significant differences appeared among the groups. On day 8, significant differences between the groups were observed in hemoglobin concentrations Group MAP was higher when compared to other groups. CONCLUSION: On day 30, hemoglobin and retinol were high, whereas C reactive protein was low. Simultaneous administration of a retinol supplement and anti-parasite treatment prevented hemoglobin reduction observed on day 8 without changes in other variables.


Assuntos
Albendazol/uso terapêutico , Antimaláricos/uso terapêutico , Ferritinas/sangue , Hemoglobinas/análise , Malária Falciparum/sangue , Malária Falciparum/tratamento farmacológico , Malária Vivax/sangue , Malária Vivax/tratamento farmacológico , Vitamina A/sangue , Vitamina A/uso terapêutico , Albendazol/administração & dosagem , Anemia/epidemiologia , Anemia/etiologia , Anemia/prevenção & controle , Antimaláricos/administração & dosagem , Proteína C-Reativa , Criança , Pré-Escolar , Colômbia/epidemiologia , Comorbidade , Quimioterapia Combinada , Feminino , Hemorragia Gastrointestinal/complicações , Hemorragia Gastrointestinal/parasitologia , Humanos , Inflamação/sangue , Inflamação/epidemiologia , Enteropatias Parasitárias/complicações , Enteropatias Parasitárias/tratamento farmacológico , Enteropatias Parasitárias/epidemiologia , Malária Falciparum/epidemiologia , Malária Vivax/epidemiologia , Masculino , Contagem de Ovos de Parasitas , Deficiência de Vitamina A/tratamento farmacológico , Deficiência de Vitamina A/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA